Ironwood to Acquire Rare Disease Specialist VectivBio for US$1 B

By Lucy Haggerty

Pharma Deals Review: Vol 2023 Issue 5 (Table of Contents)

Published: 26 May-2023

DOI: 10.3833/pdr.v2023.i5.2787     ISSN: 1756-7874

Section: Mergers & Acquisitions



In order to expand its rare gastrointestinal pipeline, Ironwood Pharmaceuticals has agreed to acquire VectivBio for an aggregate consideration of approximately US$1 B...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details